TRINITY BIOTECH MANUFACTURING LIMITED

Trinity Biotech Manufacturing Limited is a public, science-driven company specialising in the development, manufacture and marketing of clinical diagnostic products. Drawing on extensive expertise in molecular and immuno-assay technologies, the business delivers high-performance solutions that help laboratories and point-of-care settings detect disease quickly and accurately.

Key offerings include the Premier Resolution HPLC analyser, a superior system for thalassaemia and haemoglobin-variant detection, and the Bartels® FlexTrans™ Transport Medium, which suppresses microbial contamination during specimen transport. The portfolio also features a single-use immunoassay for rapid detection of HIV-1 and HIV-2 antibodies in serum, plasma or whole blood. Recent regulatory milestones - such as FDA clearance for the PreClara™ pre-eclampsia test and approval to commence off-shored manufacturing of its flagship rapid HIV test - underline the company's commitment to innovation and global market reach. Trinity Biotech's focus on reliable, cutting-edge diagnostics makes it a trusted partner for healthcare providers worldwide.